Concentrix (NASDAQ:CNXC) Issues Q1 2026 Earnings Guidance

Concentrix (NASDAQ:CNXCGet Free Report) issued an update on its first quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 2.570-2.690 for the period. The company issued revenue guidance of $2.5 billion-$2.5 billion. Concentrix also updated its FY 2026 guidance to 11.480-12.070 EPS.

Concentrix Stock Down 8.1%

Shares of NASDAQ CNXC opened at $40.48 on Tuesday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 1.10. Concentrix has a 12 month low of $31.63 and a 12 month high of $66.00. The stock has a 50-day moving average price of $38.43 and a two-hundred day moving average price of $46.77. The company has a market cap of $2.52 billion, a price-to-earnings ratio of 8.56, a PEG ratio of 0.59 and a beta of 0.48.

Concentrix (NASDAQ:CNXCGet Free Report) last announced its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a return on equity of 16.02% and a net margin of 3.25%.The company had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. During the same period in the previous year, the business earned $3.26 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, analysts forecast that Concentrix will post 10.11 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on CNXC shares. Weiss Ratings upgraded Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Canaccord Genuity Group restated a “buy” rating and issued a $80.00 target price on shares of Concentrix in a research report on Tuesday, September 23rd. Barrington Research reiterated an “outperform” rating and issued a $62.00 target price on shares of Concentrix in a research report on Monday. Robert W. Baird lowered their price objective on Concentrix from $75.00 to $62.00 and set an “outperform” rating for the company in a research report on Monday, September 29th. Finally, Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $66.25.

Check Out Our Latest Analysis on CNXC

Insider Transactions at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of Concentrix stock in a transaction that occurred on Friday, October 31st. The shares were bought at an average price of $40.00 per share, for a total transaction of $40,000.00. Following the completion of the transaction, the chief executive officer owned 287,661 shares of the company’s stock, valued at approximately $11,506,440. This trade represents a 0.35% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
  • Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
  • Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
  • Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
  • Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
  • Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
  • Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi‑year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.

Hedge Funds Weigh In On Concentrix

Hedge funds have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC lifted its holdings in Concentrix by 34.4% in the second quarter. Sivia Capital Partners LLC now owns 6,283 shares of the company’s stock valued at $332,000 after acquiring an additional 1,607 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of Concentrix in the second quarter valued at approximately $508,000. Brevan Howard Capital Management LP grew its stake in Concentrix by 4.5% during the 2nd quarter. Brevan Howard Capital Management LP now owns 8,951 shares of the company’s stock worth $473,000 after purchasing an additional 384 shares in the last quarter. Cetera Investment Advisers purchased a new stake in shares of Concentrix during the second quarter worth approximately $293,000. Finally, Focus Partners Wealth acquired a new stake in Concentrix in the first quarter valued at $781,000. 90.34% of the stock is currently owned by institutional investors.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Articles

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.